{
    "doi": "https://doi.org/10.1182/blood.V108.11.1576.1576",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=595",
    "start_url_page_num": 595,
    "is_scraped": "1",
    "article_title": "Recessive Congenital Methaemoglobinaemia: Three New Mutations in the NADH-Cytochrome b5 Reductase Gene. ",
    "article_date": "November 16, 2006",
    "session_type": "Poster Sessions",
    "topics": [
        "congenital methemoglobinemia",
        "cytochromes",
        "genes",
        "nicotinamide adenine dinucleotide (nad)",
        "oxidoreductase",
        "de novo mutation",
        "reflectance confocal microscopy",
        "protein isoforms",
        "cyanosis",
        "enzymes"
    ],
    "author_names": [
        "Elisa Fermo, PhD",
        "Paola Bianchi, PhD",
        "Cristina Vercellati, PhD",
        "Anna P. Marcello, PhD",
        "Wilma Barcellini, MD",
        "Ornella Marangoni, MD",
        "Massimo Garatti, MD",
        "Alberto Zanella, MD"
    ],
    "author_affiliations": [
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Unita\u0300 Operativa di Pediatria, Presidio Ospedaliero di San Giovanni Bianco, Bergamo, Italy"
        ],
        [
            "Centro Trasfusionale e di Immunoematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ],
        [
            "Divisione di Ematologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy"
        ]
    ],
    "first_author_latitude": "45.45884170000001",
    "first_author_longitude": "9.1949702",
    "abstract_text": "Recessive congenital methemoglobinemia (RCM) is caused by deficiency of reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase (cytb5r). The cytb5r gene ( DIA1 ) is localized on chromosome 22q13-qter and contains nine exons; tissue-specific alternative transcripts originate 275-amino acid soluble and 300-amino acid membrane-bound isoforms. Cytb5r deficiency exists in two distinct clinical forms: in Type-I the enzyme deficiency is restricted to the red cell-soluble cytb5r isoform and results in cyanosis; in Type-II the enzyme defect involves both the soluble and membrane-bound isoforms, and severe neurological impairment is also present. More than 40 different mutations of DIA1 gene have been reported in RCM: disruptive mutations (stop, frameshift, splicing) are in general associated with the severe Type-II disease. We report the clinical, hematological and molecular characterisation 6 new patients affected by RCM (Table 1). Mutations reported in italic are new. The study of cytb5r enzyme showed a drastic reduction of activity in all patients. Parents displayed intermediate values characteristics of an heterozygous state. Mutation IVS5+2 t-c at the homozygous state was found in Type-II RCM (case 1) as already reported by Yilmaz et al (2005) in one patient; this variant is likely to cause alteration of mRNA splicing and subsequent absence of functional protein in all tissues, therefore accounting for the severe clinical pattern. V252M is the most common DIA1 gene mutation and has been reported in both Type-I and -II homozygous patients; the finding that this mutation in association with the new, very disruptive Gln28STOP mutation results in a benign phenotype (case 4), suggests that V252M is more likely to behave as a \u201cType-I\u201d mutation. In case 6, in spite of cyanosis present since childhood, diagnosis of RCM Type-I was made in adult age because of polycythemia. In fact, significant compensatory elevation of hemoglobin concentration is sometimes observed in patients with congenital methemoglobinemia.  Patient, (age) . Type . MetHb(%) . Hb (g/dL) . Hct (%) . Cytb5r activity (IU/gHb) . Mutations . Effect . 1 (8months) II 12.1 12.2 36.5 1.4 IVS5+2 t-c/IVS5+2 t-c Splicing/splicing 2 (2months) I 26.2 11.9 35.6 0.9 Cod.143 GGC-GAC/Cod.143 GGC-GAC Gly143Asp/Gly143Asp  3 (4months) I 12.4 16.6 49 1.7 Cod 218 CGA-TGA/Cod 105 GTG-ATG Arg218STOP/Val105Met 4 (1month) I 25.7 14.9 45 0 Cod 28 CAG-TAG/Cod. 252 GTG-ATG Gln28STOP /Val252Met 5 (1month) I Nd 12.2 35 1.9 Cod 46 CGG-TGG/Cod. 252 GTG-ATG Arg46Trp /Val252Met 6 (47years) I 23.7 18.6 55 0 cod 144 CCC-TCC/cod 252 GTG-ATG Pro144Ser/Val 252Met   0.5\u20131.5 12\u201316 39\u201349 15.4\u201323.1   Patient, (age) . Type . MetHb(%) . Hb (g/dL) . Hct (%) . Cytb5r activity (IU/gHb) . Mutations . Effect . 1 (8months) II 12.1 12.2 36.5 1.4 IVS5+2 t-c/IVS5+2 t-c Splicing/splicing 2 (2months) I 26.2 11.9 35.6 0.9 Cod.143 GGC-GAC/Cod.143 GGC-GAC Gly143Asp/Gly143Asp  3 (4months) I 12.4 16.6 49 1.7 Cod 218 CGA-TGA/Cod 105 GTG-ATG Arg218STOP/Val105Met 4 (1month) I 25.7 14.9 45 0 Cod 28 CAG-TAG/Cod. 252 GTG-ATG Gln28STOP /Val252Met 5 (1month) I Nd 12.2 35 1.9 Cod 46 CGG-TGG/Cod. 252 GTG-ATG Arg46Trp /Val252Met 6 (47years) I 23.7 18.6 55 0 cod 144 CCC-TCC/cod 252 GTG-ATG Pro144Ser/Val 252Met   0.5\u20131.5 12\u201316 39\u201349 15.4\u201323.1   View Large"
}